.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Julphar
Cerilliant
Moodys
Accenture
Express Scripts
Mallinckrodt
Johnson and Johnson
Boehringer Ingelheim
Fish and Richardson

Generated: September 20, 2017

DrugPatentWatch Database Preview

POLYCILLIN-PRB Drug Profile

« Back to Dashboard

What is the patent landscape for Polycillin-prb, and when can generic versions of Polycillin-prb launch?

Polycillin-prb is a drug marketed by Bristol and Apothecon and is included in two NDAs.

The generic ingredient in POLYCILLIN-PRB is ampicillin/ampicillin trihydrate; probenecid. Additional details are available on the ampicillin/ampicillin trihydrate; probenecid profile page.

Summary for Tradename: POLYCILLIN-PRB

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list66
Clinical Trials: see list16
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:POLYCILLIN-PRB at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol
POLYCILLIN-PRB
ampicillin/ampicillin trihydrate; probenecid
FOR SUSPENSION;ORAL050457-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
POLYCILLIN-PRB
ampicillin/ampicillin trihydrate; probenecid
FOR SUSPENSION;ORAL061898-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Cipla
Johnson and Johnson
Mallinckrodt
AstraZeneca
US Army
Federal Trade Commission
Queensland Health
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot